Expression of GPI-anchored CD59 has been shown to be neuroprotective in neurons and decreased expression has been reported in the brains of patients with Alzheimer’s Disease (AD) [15], and aberrant Glypican processing has been detected in the context of AD and Niemann-Pick Disease [16, 17]. The gene discussed is GPC1; the disease is Niemann-Pick disease.